Full Text View
Tabular View
No Study Results Posted
Related Studies
Disulfiram for Cocaine-Alcohol Abuse - 3
This study has been completed.
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes
Sponsors and Collaborators: National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00000278
  Purpose

The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.


Condition Intervention Phase
Alcohol-Related Disorders
Cocaine-Related Disorders
Drug: Disulfiram
Phase II

Study Type: Interventional
Study Design: Treatment
Official Title: Disulfiram for Cocaine-Alcohol Abuse

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Side effects
  • Cocaine effects

Estimated Enrollment: 0
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000278

Locations
United States, Connecticut
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
VA Connecticut Healthcare System
Investigators
Principal Investigator: Thomas R Kosten, M.D. VA Connecticut Healthcare System
  More Information

No publications provided

Study ID Numbers: NIDA-09250-3, P50-09250-3
Study First Received: September 20, 1999
Last Updated: August 16, 2005
ClinicalTrials.gov Identifier: NCT00000278     History of Changes
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Disulfiram
Cocaine-Related Disorders
Mental Disorders
Alcoholism
Substance-Related Disorders
Disorders of Environmental Origin
Alcohol-Related Disorders
Cocaine
Ethanol

Additional relevant MeSH terms:
Cocaine-Related Disorders
Disulfiram
Disease
Molecular Mechanisms of Pharmacological Action
Disorders of Environmental Origin
Enzyme Inhibitors
Pharmacologic Actions
Pathologic Processes
Mental Disorders
Therapeutic Uses
Alcoholism
Substance-Related Disorders
Alcohol-Related Disorders
Central Nervous System Agents
Alcohol Deterrents

ClinicalTrials.gov processed this record on July 02, 2009